FMR LLC, a parent holding company, has filed an amended Schedule 13G/A with the Securities and Exchange Commission, disclosing a 6.129% ownership stake in Invivyd Inc., amounting to 7,320,982 shares of common stock. This amendment, dated November 8, 2024, represents a regulatory filing requirement for entities owning more than five percent of a company's stock. Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, and through the Johnson family's voting agreement, may be deemed to have a controlling influence over FMR LLC. The filing indicates that the shares were acquired in the ordinary course of business, not with the purpose of changing or influencing the control of Invivyd Inc. The address of Invivyd's principal executive offices is listed as 1601 Trapelo Road, Suite 178, Waltham, MA 02451, USA.

FMR LLC, a parent holding company, has filed an amended Schedule 13G/A with the Securities and Exchange Commission, disclosing a 6.129% ownership stake in Invivyd Inc., amounting to 7,320,982 shares of common stock. This amendment, dated November 8, 2024, represents a regulatory filing requirement for entities owning more than five percent of a company's stock. Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, and through the Johnson family's voting agreement, may be deemed to have a controlling influence over FMR LLC. The filing indicates that the shares were acquired in the ordinary course of business, not with the purpose of changing or influencing the control of Invivyd Inc. The address of Invivyd's principal executive offices is listed as 1601 Trapelo Road, Suite 178, Waltham, MA 02451, USA.